XXXX after renal transplantation.

@entity1 @entity146 @entity5 @entity150 @entity204
OBJECTIVE: After solid organ transplantation, risk of @entity5 varies significantly based on @entity5 type. In this study, we determine the incidence of @entity5 (bladder and kidney) after renal transplantation from a single high-volume transplantation institution. In addition, we analyze the risk factors and review outcomes from the @entity1 . MATERIALS AND METHODS: We performed a retrospective review of all @entity1 in the University of Alabama at Birmingham (UAB) transplant database to identify all @entity1 who received renal transplants at UAB between January 1, 1990, and January 1, 2010. We further identified transplant @entity1 diagnosed with bladder, urothelial of other @entity5 in the same time period. We also examined @entity5 -specific variables such as presentation, clinical and pathologic staging, treatment type, recurrence, progression, interval to recurrence and progression, @entity5 -specific mortality, and interval from time to diagnosis to @entity204 . RESULTS: Review of the transplant database confirmed 5,920 renal transplants. Thirteen @entity1 underwent the diagnosis of @entity5 , providing an incidence of 0.2%. Eight @entity1 had @entity150 for an incidence of 0.13%, compared to an incidence of 0.02% among the general population. @entity1 diagnosed with @entity150 after renal transplantation were younger than those in the general population and frequently present with more advanced and @entity146 . CONCLUSIONS: @entity1 are at an elevated risk of @entity5 after renal transplantation probably from immune suppression.
